Skip to contentA
Aeternum Health, Inc.
A
AETNAeternum Health, Inc. Q4 2024 · 10-K
derived · Computed from the longer spans the company filed.
Revenue$12.48K$12.48Kderivedno prior Q4 2023 on file Net Income-$139.31K-$139.31KderivedN/M vs Q4 2023 EPS, diluted—
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Aeternum Health, Inc. · CIK 764630 · Engraved from SEC EDGAR
Not derived. Share counts vary by quarter.
Gross Profitderived-$21,527— Operating Incomederived-$122,397— Operating Cash Flowderived-$1,048N/M Margins · derivedGross margin-172.5%
Operating margin-980.7%
Net margin-1116.3%
ended Dec 31, 2024 · filed Apr 15, 2025 · 105 d after period end